Inhibition of <i>N</i>-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication

Cancer suppression through the inhibition of <i>N</i>-acetyltransferase 10 (NAT10) by its specific inhibitor Remodelin has been demonstrated in a variety of human cancers. Here, we report the inhibitory effects of Remodelin on prostate cancer (PCa) cells and the possible associated mecha...

Full description

Bibliographic Details
Main Authors: Ningning Ma, Haijing Liu, Yaqian Wu, Mengfei Yao, Bo Zhang
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/12/6573
_version_ 1797486523448295424
author Ningning Ma
Haijing Liu
Yaqian Wu
Mengfei Yao
Bo Zhang
author_facet Ningning Ma
Haijing Liu
Yaqian Wu
Mengfei Yao
Bo Zhang
author_sort Ningning Ma
collection DOAJ
description Cancer suppression through the inhibition of <i>N</i>-acetyltransferase 10 (NAT10) by its specific inhibitor Remodelin has been demonstrated in a variety of human cancers. Here, we report the inhibitory effects of Remodelin on prostate cancer (PCa) cells and the possible associated mechanisms. The prostate cancer cell lines VCaP, LNCaP, PC3, and DU145 were used. The in vitro proliferation, migration, and invasion of cells were measured by a cell proliferation assay, colony formation, wound healing, and Transwell assays, respectively. In vivo tumor growth was analyzed by transplantation into nude mice. The inhibition of NAT10 by Remodelin not only suppressed growth, migration, and invasion in vitro, but also the in vivo cancer growth of prostate cancer cells. The involvement of NAT10 in DNA replication was assessed by EdU labeling, DNA spreading, iPOND, and ChIP-PCR assays. The inhibition of NAT10 by Remodelin slowed DNA replication. NAT10 was detected in the prereplication complex, and it could also bind to DNA replication origins. Furthermore, the interaction between NAT10 and CDC6 was analyzed by Co-IP. The altered expression of NAT10 was measured by immunofluorescence staining and Western blotting. Remodelin markedly reduced the levels of CDC6 and AR. The expression of NAT10 could be altered under either castration or noncastration conditions, and Remodelin still suppressed the growth of in vitro-induced castration-resistant prostate cancers. The analysis of a TCGA database revealed that the overexpression of NAT10, CDC6, and MCM7 in prostate cancers were correlated with the Gleason score and node metastasis. Our data demonstrated that Remodelin, an inhibitor of NAT10, effectively inhibits the growth of prostate cancer cells under either no castration or castration conditions, likely by impairing DNA replication.
first_indexed 2024-03-09T23:35:25Z
format Article
id doaj.art-bf1ec934d21f48bfad5dd57b2b5d6ada
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T23:35:25Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-bf1ec934d21f48bfad5dd57b2b5d6ada2023-11-23T17:03:05ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-06-012312657310.3390/ijms23126573Inhibition of <i>N</i>-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA ReplicationNingning Ma0Haijing Liu1Yaqian Wu2Mengfei Yao3Bo Zhang4Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing 100191, ChinaDepartment of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing 100191, ChinaDepartment of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing 100191, ChinaDepartment of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing 100191, ChinaDepartment of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing 100191, ChinaCancer suppression through the inhibition of <i>N</i>-acetyltransferase 10 (NAT10) by its specific inhibitor Remodelin has been demonstrated in a variety of human cancers. Here, we report the inhibitory effects of Remodelin on prostate cancer (PCa) cells and the possible associated mechanisms. The prostate cancer cell lines VCaP, LNCaP, PC3, and DU145 were used. The in vitro proliferation, migration, and invasion of cells were measured by a cell proliferation assay, colony formation, wound healing, and Transwell assays, respectively. In vivo tumor growth was analyzed by transplantation into nude mice. The inhibition of NAT10 by Remodelin not only suppressed growth, migration, and invasion in vitro, but also the in vivo cancer growth of prostate cancer cells. The involvement of NAT10 in DNA replication was assessed by EdU labeling, DNA spreading, iPOND, and ChIP-PCR assays. The inhibition of NAT10 by Remodelin slowed DNA replication. NAT10 was detected in the prereplication complex, and it could also bind to DNA replication origins. Furthermore, the interaction between NAT10 and CDC6 was analyzed by Co-IP. The altered expression of NAT10 was measured by immunofluorescence staining and Western blotting. Remodelin markedly reduced the levels of CDC6 and AR. The expression of NAT10 could be altered under either castration or noncastration conditions, and Remodelin still suppressed the growth of in vitro-induced castration-resistant prostate cancers. The analysis of a TCGA database revealed that the overexpression of NAT10, CDC6, and MCM7 in prostate cancers were correlated with the Gleason score and node metastasis. Our data demonstrated that Remodelin, an inhibitor of NAT10, effectively inhibits the growth of prostate cancer cells under either no castration or castration conditions, likely by impairing DNA replication.https://www.mdpi.com/1422-0067/23/12/6573<i>N</i>-acetyltransferase 10DNA replicationprostate cancerCRPCprogression
spellingShingle Ningning Ma
Haijing Liu
Yaqian Wu
Mengfei Yao
Bo Zhang
Inhibition of <i>N</i>-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication
International Journal of Molecular Sciences
<i>N</i>-acetyltransferase 10
DNA replication
prostate cancer
CRPC
progression
title Inhibition of <i>N</i>-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication
title_full Inhibition of <i>N</i>-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication
title_fullStr Inhibition of <i>N</i>-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication
title_full_unstemmed Inhibition of <i>N</i>-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication
title_short Inhibition of <i>N</i>-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication
title_sort inhibition of i n i acetyltransferase 10 suppresses the progression of prostate cancer through regulation of dna replication
topic <i>N</i>-acetyltransferase 10
DNA replication
prostate cancer
CRPC
progression
url https://www.mdpi.com/1422-0067/23/12/6573
work_keys_str_mv AT ningningma inhibitionofiniacetyltransferase10suppressestheprogressionofprostatecancerthroughregulationofdnareplication
AT haijingliu inhibitionofiniacetyltransferase10suppressestheprogressionofprostatecancerthroughregulationofdnareplication
AT yaqianwu inhibitionofiniacetyltransferase10suppressestheprogressionofprostatecancerthroughregulationofdnareplication
AT mengfeiyao inhibitionofiniacetyltransferase10suppressestheprogressionofprostatecancerthroughregulationofdnareplication
AT bozhang inhibitionofiniacetyltransferase10suppressestheprogressionofprostatecancerthroughregulationofdnareplication